Tecovirimat
| Usage | Recommendation | Comments |
|---|---|---|
| Oral | 600 mg po q8h x14 days | Manufacturer PI recommendations for pediatric and adult patients weighing ≥120 kg. |
| Parenteral | 300 mg IV (over 6 hr) q12h x14 days | Manufacturer PI recommendations for pediatric and adult patients weighing ≥120 kg. |